Based on the a priori analytic criteria, would they have suggested patients not use a glass of milk?
New Guidance on Insomnia Drugs Published — Physician’s First Watch
New Guidance on Insomnia Drugs Published
By Kelly Young
Edited by Richard Saitz, MD, MPH, FACP, DFASAM
The American Academy of Sleep Medicine offers new guidelines on using prescription and over-the-counter drugs to treat chronic insomnia in adults.
Published in the Journal of Clinical Sleep Medicine, all of the recommendations are weak, based on low quality of evidence. Many studies are funded by pharmaceutical companies, and there are few trials for any given drug.
The guidelines recommend a range of medications to treat both sleep-onset and sleep-maintenance insomnia. The group recommends against using trazodone, tiagabine, diphenhydramine, melatonin, tryptophan, and valerian — not because these treatments don't work, but rather, the available data don't provide "convincing support in favor of usage."
Editorialists conclude: "The choice of sleep-promoting medication is ultimately a matter of clinical judgment based on patient profile and preferences, prior response, and consideration of adverse effects... The current guideline is an additional tool to aid the clinician and patient in making the best decision for the patient."